Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sensus Healthcare (SRTS) Interest & Investment Income (2016 - 2024)

Sensus Healthcare has reported Interest & Investment Income over the past 9 years, most recently at $279000.0 for Q3 2024.

  • Quarterly results put Interest & Investment Income at $279000.0 for Q3 2024, up 0.72% from a year ago — trailing twelve months through Sep 2024 was $979000.0 (down 2.1% YoY), and the annual figure for FY2022 was $382000.0, up 19000.0%.
  • Interest & Investment Income for Q3 2024 was $279000.0 at Sensus Healthcare, up from $209000.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for SRTS hit a ceiling of $279000.0 in Q3 2024 and a floor of $1000.0 in Q4 2021.
  • Median Interest & Investment Income over the past 5 years was $164000.0 (2022), compared with a mean of $136714.3.
  • Biggest five-year swings in Interest & Investment Income: crashed 97.32% in 2020 and later surged 24200.0% in 2023.
  • Sensus Healthcare's Interest & Investment Income stood at $2000.0 in 2020, then crashed by 50.0% to $1000.0 in 2021, then soared by 23400.0% to $235000.0 in 2022, then rose by 17.87% to $277000.0 in 2023, then increased by 0.72% to $279000.0 in 2024.
  • The last three reported values for Interest & Investment Income were $279000.0 (Q3 2024), $209000.0 (Q2 2024), and $214000.0 (Q1 2024) per Business Quant data.